Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy

Published:2021-12-19 Issue: Volume: Page:1-12
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Richard Guilhem¹^ORCID,Princiotta Michael F.¹^ORCID,Bridon Dominique¹,Martin William D.²^ORCID,Steinberg Gary D.¹³^ORCID,De Groot Anne S.²⁴^ORCID

Affiliation:

1. EpiVax Therapeutics, Inc., Providence, RI, USA

2. EpiVax, Inc., Providence, RI, USA

3. Perlmutter Cancer Center, Department of Urology at NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA

4. Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2012456

Reference108 articles.

2. Pembrolizumab: First Global Approval

3. Nivolumab: A Review of Its Use in Patients with Malignant Melanoma

4. Cemiplimab: First Global Approval

5. Dostarlimab: First Approval

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer therapy via neoepitope-specific monoclonal antibody cocktails;2024-08-06

2. Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers;npj Vaccines;2024-05-31

3. Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis;Frontiers in Immunology;2024-05-15

4. Recent Findings on Therapeutic Cancer Vaccines: An Updated Review;Biomolecules;2024-04-21

5. In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies;mAbs;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3